Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

Click here for the full Philadelphia Agenda.

Last industry pushing year's agenda


NOTE: Attendance to this session is not included in the Silver or Gold Pass. If you would like to attend, make sure you either select the Diamond Pass or select it as an option when you register here - http://www.eyeforpharma.com/philadelphia/register.php

Taking place at the Marriott Downtown, Philadelphia



Most Valuable Patient Initiative

The finalists of this award are innovative projects designed to deliver tangible patient improvements both in the long and short term. Demonstrating real understanding for the patient requirements prior to implementation, these finalists have been managed to an outstanding level and have made an exceptionally positive impact on their intended customer.

11:00AM - 11:15AM
Changing the course of psoriasis treatment with patients

Janssen Janssen

11:15AM - 11:30AM
nCompass

Novocure Novocure

1:30AM - 11:45AM
Seeing the Patient's Perspective

Regeneron and Intouch Solutions Regeneron and Intouch Solutions

11:45AM - 12:00PM
Global Trial Community

Janssen Janssen

12:00PM - 12:15PM
HemMobile Striiv Wearable

Pfizer Pfizer

NOTE: This session takes place on April 9th and this day is NOT included in a silver, gold or diamond pass. You must select the “eyeforpharma Judging Day” option when checking out to have access. Register here.
The Patient Advocate Award

The winner of this award will be an innovative project designed to deliver tangible patient improvements both in the long and short term. Demonstrating real understanding for the patient requirements prior to implementation, the winning project will have been managed to an outstanding level and will have made an exceptionally positive impact on its intended customer. Please indicate in your nomination how the project generated new knowledge which will ensure longevity or aid in future initiatives.

12:15PM - 12:30PM
Todd Stephenson

Janssen Janssen

12:30PM - 1:30PM
TBC

Company_Name TBC

1:30PM - 1:45PM
Jen Horonjeff

Savvy Cooperative Savvy Cooperative

1:45PM - 2:00PM
Sarah Krug

Cancer101 Cancer101

2:00PM - 2:15PM
Heidi Floyd

Pink Power Mom Pink Power Mom

NOTE: This session takes place on April 9th and this day is NOT included in a silver, gold or diamond pass. You must select the “eyeforpharma Judging Day” option when checking out to have access. Register here.
Most Valuable Healthcare Initiative

The finalists of this award are innovative projects designed to deliver tangible working and healthcare improvements both in the long and short term. Demonstrating understanding of real health requirements prior to implementation, these winning projects have been managed to an outstanding level and have made an exceptionally positive impact on their intended customer.

2:15PM - 2:30PM
Bayer Oncology Augmented and Virtual Reality Experience

Bayer Bayer

PIXACORE PIXACORE

2:30PM - 2:45PM
Patient Assessment in COPD (PAC)

Boehringer Ingelheim and CTC Communications Boehringer Ingelheim and CTC Communications

2:45PM - 3:00PM
Development of a claims-based algorithm for use in migraine patients to identify potentially undiagnosed chronic migraine patients

Allergan with HealthCare partners Allergan with HealthCare partners

3:00PM - 3:15PM
BD Vascular Access Management (VAM)

BD BD

3:15PM - 3:30PM
Interactive ALSFRS-R Digital Detail

Mitsubishi Tanabe Pharma America Mitsubishi Tanabe Pharma America

inVentic Health inVentic Health

3:30PM - 4:00PM
Coffee Break
NOTE: This session takes place on April 9th and this day is NOT included in a silver, gold or diamond pass. You must select the “eyeforpharma Judging Day” option when checking out to have access. Register here.
Most Valuable Collaboration

The finalists of this award are either a pharma-pharma or pharma-non-pharma initiative which clearly brings a new proposition to customers and/or healthcare systems, creates new value and redefines what is possible in our industry with a degree of lateral thinking.

4:00PM - 4:15PM
Child Neurology Foundation's Respite Care Handbook

GSK and Child Neurology Foundation GSK and Child Neurology Foundation

4:15PM - 4:30PM
HemMobile Striiv Wearable

Pfizer and Striiv Pfizer and Striiv

4:30PM - 4:45PM
IBS-D Patient Engagement Platform

Allergan, SonarMD and Illinois Gastroenterology Group (IGG) Allergan, SonarMD and Illinois Gastroenterology Group (IGG)

4:45PM - 5:00PM
Making Medicines: The Process of Drug Development eLearning course

Eli Lilly and partners Eli Lilly and partners

5:00PM - 5:15PM
Hemocraft - Reimagining Patient Education

Pfizer, Drexel University and National Haemophilia Foundation (NHF) Pfizer, Drexel University and National Haemophilia Foundation (NHF)

Taking place at the Marriott Downtown, Philadelphia



2:00PM - 6:00PM
Amazon Workshop: Working Backwards

NOTE: Attendance to this session is not included in the Silver or Gold Pass. If you would like to attend, make sure you either select the Diamond Pass or select it as an option when you register here - http://www.eyeforpharma.com/philadelphia/register.php

Inside Amazon's approach to inventing new products and services are a set of simple yet effective activities designed to drive clarity and focus for teams. Getting this process right is a key part of what has given Amazon its reputation for customer obsession, high degree of loyalty, and successful track record of consistent growth and product launches.

Amazon has developed a deceptively straightforward methodology that can be applied to every major initiative. This hands-on workshop, called 'Working Backwards', will be run by Amazon leaders and adapted to the needs of tomorrow's pharmaceutical executives who wish to improve internal culture and working practices.

Attend this workshop to:

  • Learn the simple activities that Amazon employ to drive true customer-centricity in the way you develop services for customers.
  • Understand how to work with the customer always in your mind by learning how to develop a Working Backwards document which includes a press release, FAQs and visuals.
7:30AM - 8:25AM
Registration & Welcome Coffee in the Exhibition Hall
8:25AM - 8:40AM
Opening Address

eyeforpharma Paul Simms Chairperson eyeforpharma

Plus insights from: Idea Couture, a Cognizant Digital Business Company Ryan Doyle VP Strategy, Health Idea Couture, a Cognizant Digital Business Company

8:40AM - 9:05AM
The empowered patient: Building a partnership of trust
  • Recognize the growing need to better understand life with disease, and the role of the patient and caregiver in providing vital insights across the entire drug lifecycle
  • Discover ways to operationalize patient engagement, implementing a robust framework which works across all functions
  • Identify authentic patient communications insights – and understand when and where a closer relationship can help improve a patient’s healthcare experience

Alkermes Jim Robinson President & COO Alkermes

9:05AM - 9:35AM
Transforming access to therapy through innovations along the patient journey
  • Optimize patient access through seamless connectivity between physicians, payers, pharmacies and biopharma companies
  • Provide continuity of care from the first patient-HCP discussion through to comprehensive adherence support
  • Enhance visibility into the patient journey and deliver timely interventions through innovative technology an integrated patient support programs

McKesson Specialty Health Bill Nolan VP & General Manager McKesson Speciality Health

CoverMyMeds Glenn Wada President CoverMyMeds

9:35AM - 9:50AM
Winners Announced for The eyeforpharma Awards:
Most Valuable Patient Initiative & Most Valuable Patient Advocate
9:50AM - 10:15AM
Bring humanity back to healthcare
  • Why we must recognize the danger of putting a premium on systems, data and processes, and neglecting human relationships
  • Has pharma lost its humanity? Avoid the endless restructuring of our commercial model and bring back partnerships with authenticity
  • How to translate humanity into the physician’s office: use category management and medical education to build credibility and establish long-term customers. Witness how Ferring are achieving this in the fertility domain.

Ferring Holdings Inc Paul Navarre CEO Ferring Holding Inc. US

10:15AM - 10:45AM
Networking Coffee Break in the Exhibition Hall
10:45AM - 11:10AM
Algorithms Unleashed: The need to reinvent our role in delivering patient value
  • Why harnessing AI and Deep Learning is crucial if we want to deliver patient value
  • How AI is impacting global workforces, freeing up companies to find new ways to deliver value to customers and how pharma can learn from this to deliver even more value to patients
  • Why we need to have strategies to attract and retain AI talent as well as for the re-skilling our own employees, in the interest of developing the capabilities to harness AI appropriately for patients.
  • Explore why we need to reimagine and reinvent the role we as humans play in delivering value to patients.

UCB Bharat Tewarie EVP & Chief Marketing Officer UCB

11:10AM - 11:40AM
Walking the walk: How patient-centric business models can drive measurable value for the organization
  • Do you ever wonder if pharmaceutical companies are just paying lip service to the concept of patient centricity? Can companies not just talk the talk, but actually walk the walk?
  • Succeeding in pharma today means getting better at understanding patients and their needs in order to deliver meaningful patient experiences and improve outcomes.
  • Learn how successful companies are organizing and adapting to become more patient-centric, and how they’re measuring the impact that these changes are having on their businesses.
  • Assess where your company lies on the path toward patient centricity and learn four critical skills that will help you improve.

ZS Associates Hensley Evans Principal ZS Associates

11:40AM - 11:55AM
Winners Announced for The eyeforpharma Awards:
Most Valuable Healthcare Initiative & Most Valuable Collaboration
11:55AM - 1:05PM
Lunch in the Exhibition Hall

PLUS, Lunch & Learn on how to unleash the power of “moment marketing with Guidemark. (pharma and bop company attendees only) in Room 112A.

Medical Affairs
1:05PM - 1:15PM
Chairperson’s Opening Address

Medscape Katie Anders Head of Medical Affairs Strategic Solutions (MASS) Medscape

1:15PM - 1:55PM
Panel: Meet the needs of an increasingly demanding external environment with a new value-driven medical model
  • Connect and champion patient and real-world data activities throughout your organization by acting as the network between silos
  • Develop and source the new set of capabilities required to enable medical’s full potential
  • Ensure long-term success by adapting now to the next generation of patients, physicians and KOLs with increased access to medical data and research

Ipsen Sotirios Stergiopoulos CMO, SVP and Head of Global Medical Affairs Ipsen

AstraZeneca Sandy Leonard VP of Medical Evidence & Observational Research AstraZeneca

EMD Serono Zhen Su Chief Medical Officer, North America EMD Serono

Alnylam Pharmaceuticals Dr. Pritesh Gandhi PharmD, VP, Medical Affairs Alnylam Pharmaceuticals

1:55PM - 2:25PM
Promoting the patient voice in evidence generation and global market access planning
  • Learn about the challenges of real-world evidence and marketplace demands for supporting new treatments
  • Understand important regulatory and payer perspectives on patient-centric data in decision-making
  • Explore effective examples of leveraging the patient voice in RWE research to leverage direct-to-patient opportunities

PAREXEL Thom Schoenwaelder Vice President PAREXEL

PAREXEL Leanne Larson, MHA Corporate Vice President & WW Head, Real-World Evidence Strategy PAREXEL Consulting

2:25PM - 2:55PM
Direct more meaningful internal policy by representing the patient voice across functions
  • Create a more complete picture of the patient journey by using insights from across stakeholder touchpoints and RWD sources
  • Bring more patient insights inwards with increased direct interaction through advocacy groups and organizations
  • Develop new patient value metrics to better inform approach and effectively communicate need to decision makers

Pfizer Oncology Lynn McRoy Senior Director and Team Lead, Breast Cancer, US Medical Affairs Pfizer Oncology

2:55PM - 3:25PM
Early engagement of Medical Affairs in product development: A new frontier to drive R&D innovation and linking “Proof of Concepts” to “Proof of Medical Value”
  • Bring diverse stakeholder insights (patients, payers, providers) early and successfully into the clinical-regulatory development process
  • Develop “must have” components of TPP and successfully translate into a cohesive end point strategy

Trevena, Inc. Usman Iqbal MD, MPH, MBA, Senior Director, Medical Affairs & HEOR Trevena, Inc.

3:25PM - 3:55PM
Networking Coffee Break in the Exhibition Hall
3:55PM - 4:25PM
Find customer's unmet needs with use of enhanced scientific principles in evidence generation
  • Witness the evolving role of Medical Affairs in translating unmet need into a manageable process
  • Explore how to unlock greater product value and differentiation through the “Evidence Development Process”
  • Understand how this evidence generation management can solve unmet needs more effectively

Nestlé Juan Ochoa Chief Medical Officer, US Nestlé

4:25PM - 4:55PM
Role of Medical Affairs as the “value cockpit” For Life Sciences – transition to become the control center for Medical Value to external and internal stakeholders for clinical and commercial execution
  • Imagine how Medical Affairs can evolve science and evidence-based communication to enhance customer engagement
  • Explore potential applications of digital in managing value & outcomes
  • Learn how to manage the proliferation of data/RWD, while meeting demands for transparency

Cognizant Vyom Bhuta Global Partner, Commercial Life Sciences & Digital Business Cognizant

Cognizant Barinder Marhok Global Practice Lead, Clinical Life Sciences Cognizant

4:55PM - 5:25PM
Embed the patient perspective into drug development to locate undiscovered value
  • Improve strategic decision-making throughout development to enhance patient and business outcomes
  • Connect key advocacy groups, patients and caregivers with internal leadership to form long-term collaboration and exchange direct insights
  • Explore how the “Embracing Carers” initiative is empowering and supporting unpaid caregivers to advocate and drive support of their wellbeing

EMD Serono Scott Williams VP, Head of Global Patient Advocacy and Strategic Relationships EMD Serono

5:25PM - 6:10PM
Panel: Address increased evidence demands with a new pharma-payer value paradigm
  • Define medical’s role with market access colleagues to increase synergy between interactions and maximize on limited contact time available
  • Tailor publication plans to the payer audience with increased understanding of decision-making factors
  • Increase research opportunities and align findings to payer preferences with a focus on collaborative claims in database studies

Blue Cross Blue Shield Association Suzanne Belinson Executive Director, Clinical Markets Blue Cross Blue Shield Association

GSK John Graham VP and Head, Value Evidence and Outcomes GSK

Novartis Vivian Herrera Executive Director, Head of HEOR Payer Strategy Novartis

6:10PM - 7:30PM
Networking Drinks Reception in the Exhibition Hall

PLUS, VIP Dinner Sponsored by Verix. Invite only.

7:20AM - 8:20AM
Registration & Welcome Coffee in the Exhibition Hall
Medical Affairs
8:20AM - 8:30AM
Chairperson’s Opening Address

PAREXEL Leanne Larson MHA, Corporate VP & WW Head, Real-World Evidence Strategy PAREXEL

8:30AM - 8:55AM
Expand your RWE horizon: look beyond data generation and explore the multitude of further uses
  • Explore the range of tools to leverage RWE to improve healthcare stakeholder (e.g. patient associations, HCPs, payers) engagement
  • Leverage new technologies to analyse healthcare trends
  • Integrate RWE in the cross-functional communication strategy of your brand value proposition

Novartis Luca Dezzani Global Brand Medical Director Novartis

8:55AM - 9:25AM
The role of registries in patient understanding for Medical Affairs in an era of ‘big data’
  • Understand the full potential of registry data amongst the RWD source spectrum, and how this fits in the realm of ‘big data'
  • Create a complete picture of the patient journey by linking registry data with other RWE sources (claims and EMR) to overcome evidence gaps
  • Explore the full range of registry data uses (comparative effectiveness & safety, cost effectiveness, real-time PRO feedback & analysis)

Corrona Joel Kremer Founder and Chief Medical Officer Corrona

9:25AM - 10:20AM
Roundtables:

Choose from one of the following 6 roundtables:

  1. The modern MSL: what are the skill requirements and how do you achieve them under constrained budgets for maximum value addition?
  2. Digital tools in medical affairs: how focus investment on technological developments for improved customer engagement and insights gathering
  3. Achieving launch excellence: the steps to create unity across Development, Medical Affairs, Access and Commercial teams
  4. Reducing the risk of outcomes-based pricing: explore medical’s role in achieving a new high bar for data requirements
  5. Patient-centricity: a hot topic, but what’s really being done and how do medical help instil a change for good?
  6. Maintaining authenticity: what’s the best approach to balance commercial and scientific pressures?

Roundtable hosts:

AstraZeneca Sandy Leonard VP of Medical Evidence & Observational Research AstraZeneca

UCB Kathy Foris Head of Medical Neurology UCB

Corrona Joel Kremer Founder and Chief Medical Officer Corrona

Pfizer Lori Stockert US Medical Affairs, Director Pfizer

10:20AM - 10:50AM
Networking Coffee Break in the Exhibition Hall
10:50AM - 11:15AM
Inform formulary and regulatory decision-making with pragmatic clinical trial (PCT) data
  • Incorporate real-world evidence study design and data into PCT planning and development
  • Learn best practices of PCT study design and execution from ongoing and completed case examples
  • Discuss regulatory and formulary decision-making considerations incorporating PCT data

AstraZeneca Eric Wittbrodt Director HEOR AstraZeneca

11:15AM - 11:45AM
Leverage the power of technology and data to take Medical Affairs to the next level
  • Map your future with expert data analysis to identify current trends and actionable insights
  • Embrace the potential of AI and VR for competitive advantage
  • Leverage emerging technologies for a personalized learning experience

Medscape Katie Anders Head of Medical Affairs Strategic Solutions (MASS) Medscape

11:45AM - 12:45PM
Lunch in the Exhibition Hall

PLUS Lunch & Learn with viihealth in Room 112A.  For pharma and bio attendees only.

12:45PM - 12:55PM
Workshop Break
12:55PM - 1:20PM
Exponential education: Accelerate the distribution of medical information by embracing Artificial Intelligence (AI)
  • Enable immediate medical request response times by investing in machine learning capabilities, automating a proportion of responses
  • Develop intelligent content personalized to requesters, using self-learning social monitoring technology
  • Become the prime destination for medical information requests by creating a reliable and seamless online interaction experience

BMS Chris Keenan Head, Worldwide Medical Customer Engagement, Medical Capabilities BMS

1:20PM - 2:00PM
Panel: Shape internal direction by effectively measuring and demonstrating medical's value
  • Create tangible KPIs that are easily measurable and relatable in comparative assessment
  • Use quantifiable external feedback on medical interactions to bring insight on field team interactions internally
  • Foster a business-focused mindset within medical teams to drive long-term change toward a more measurable model

Pfizer Eddie Power VP, US Medical Affairs Pfizer

Clinical Score Gary Kaplan VP of Medical Affairs Research Clinical Score

Takeda Canada Jefferson Tea VP Medical & Scientific Affairs Takeda Canada

UCB Kathy Foris Head of Medical Neurology UCB

2:00PM - 2:15PM
Networking Coffee Break in the Exhibition Hall

Chairperson: eyeforpharma Paul Simms Chairman eyeforpharma

2:15PM - 3:10PM
Panel: ‘Value’: focus on the common objectives amidst the chaos
  • Develop the shift to value-based care and explore its potential to set an acceptable ‘new normal’ for drug pricing
  • Discover how best to demonstrate true value of your drug when interacting with a complex array of stakeholders
  • Understand pharma’s unique position in the delivery of healthcare to understand which partnerships and collaborations are required, moving forwards

Novartis Fabrice Chouraqui President, U.S. Novartis

Lilly Oncology Sue Mahony SVP & President Lilly Oncology

PhRMA Stephen Ubl President & CEO PhRMA

V ClinBio Bob Oliver CEO & President V ClinBio

Kaiser Permanente Amy Gutierrez, Pharm.D. Vice President, Chief Pharmacy Officer Kaiser Permanente

Moderator: Legacy Health Strategies Rolf Benirschke Co-Founder and Co-CEO Legacy Health Strategies

3:10PM - 3:15PM
Announcement of the Lifetime Achievement Award Winner
3:15PM - 3:30PM
Presentation from the Winner of the Most Valuable Pharma Collaboration
3:30PM - 3:55PM
Consolidation or Transformation?
  • Learnabout a new regulatory pathway for innovative drug products that reduces time, risks and costs and can lead to increased R&D productivity
  • Explorenew commercial models that expand the definition of a pharmaceutical product and create significant new barriers to entry that do not require patents on molecules
  • Discover new manufacturing methods that build on the industry’s high volume, high quality expertise and incorporate new disciplines from the semiconductor industry

proteus_digital_health Andy Thompson CEO & co-founder Proteus Digital Health

3:55PM - 4:40PM
Panel: Big data, bigger opportunity
  • Envisage the monumental long-term effect of real world data informing customers as well as ourselves; particularly with regard to drug discovery, patient access and commercialization
  • Understand the trajectory and adoption of sensors to collect real-time patient insight and their future implications
  • Realize the potential in the analytics of vast quantities of data and where this will influence prescribers, payers, policy makers and other stakeholders

Abbvie Rob Scott Vice President, Development and Chief Medical Officer Abbvie

EMD Serono Zhen Su Senior Vice President & CMO EMD Serono

Moderna Therapeutics Marcello Damiani Chief Digital Officer Moderna Therapeutics

Pfizer Chris Boone VP, Real World Data & Analytics Center of Excellence, Patient & Health Pfizer

Salesforce Susan Emerson VP, Analytics and AI Salesforce

Moderator: Amazon Web Services Lita Sands Global Life Sciences Principal Amazon Web Services

4:40PM
End of Summit
7:30AM - 8:25AM
Registration & Welcome Coffee in the Exhibition Hall
8:25AM - 8:40AM
Opening Address

eyeforpharma Paul Simms Chairperson eyeforpharma

Plus insights from: Idea Couture, a Cognizant Digital Business Company Ryan Doyle VP Strategy, Health Idea Couture, a Cognizant Digital Business Company

8:40AM - 9:05AM
The empowered patient: Building a partnership of trust
  • Recognize the growing need to better understand life with disease, and the role of the patient and caregiver in providing vital insights across the entire drug lifecycle
  • Discover ways to operationalize patient engagement, implementing a robust framework which works across all functions
  • Identify authentic patient communications insights – and understand when and where a closer relationship can help improve a patient’s healthcare experience

Alkermes Jim Robinson President & COO Alkermes

9:05AM - 9:35AM
Transforming access to therapy through innovations along the patient journey
  • Optimize patient access through seamless connectivity between physicians, payers, pharmacies and biopharma companies
  • Provide continuity of care from the first patient-HCP discussion through to comprehensive adherence support
  • Enhance visibility into the patient journey and deliver timely interventions through innovative technology an integrated patient support programs

McKesson Specialty Health Bill Nolan VP & General Manager McKesson Speciality Health

CoverMyMeds Glenn Wada President CoverMyMeds

9:35AM - 9:50AM
Winners Announced for The eyeforpharma Awards:
Most Valuable Patient Initiative & Most Valuable Patient Advocate
9:50AM - 10:15AM
Bring humanity back to healthcare
  • Why we must recognize the danger of putting a premium on systems, data and processes, and neglecting human relationships
  • Has pharma lost its humanity? Avoid the endless restructuring of our commercial model and bring back partnerships with authenticity
  • How to translate humanity into the physician’s office: use category management and medical education to build credibility and establish long-term customers. Witness how Ferring are achieving this in the fertility domain.

Ferring Holdings Inc Paul Navarre CEO Ferring Holding Inc. US

10:15AM - 10:45AM
Networking Coffee Break in the Exhibition Hall
10:45AM - 11:10AM
Algorithms Unleashed: The need to reinvent our role in delivering patient value
  • Why harnessing AI and Deep Learning is crucial if we want to deliver patient value
  • How AI is impacting global workforces, freeing up companies to find new ways to deliver value to customers and how pharma can learn from this to deliver even more value to patients
  • Why we need to have strategies to attract and retain AI talent as well as for the re-skilling our own employees, in the interest of developing the capabilities to harness AI appropriately for patients.
  • Explore why we need to reimagine and reinvent the role we as humans play in delivering value to patients.

UCB Bharat Tewarie EVP & Chief Marketing Officer UCB

11:10AM - 11:40AM
Walking the walk: How patient-centric business models can drive measurable value for the organization
  • Do you ever wonder if pharmaceutical companies are just paying lip service to the concept of patient centricity? Can companies not just talk the talk, but actually walk the walk?
  • Succeeding in pharma today means getting better at understanding patients and their needs in order to deliver meaningful patient experiences and improve outcomes.
  • Learn how successful companies are organizing and adapting to become more patient-centric, and how they’re measuring the impact that these changes are having on their businesses.
  • Assess where your company lies on the path toward patient centricity and learn four critical skills that will help you improve.

ZS Associates Hensley Evans Principal ZS Associates

11:40AM - 11:55AM
Winners Announced for The eyeforpharma Awards:
Most Valuable Healthcare Initiative & Most Valuable Collaboration
11:55AM - 1:05PM
Lunch in the Exhibition Hall

PLUS, Lunch & Learn on how to unleash the power of “moment marketing with Guidemark. (pharma and bop company attendees only) in Room 112A.

Medical Affairs
1:05PM - 1:15PM
Chairperson’s Opening Address

Medscape Katie Anders Head of Medical Affairs Strategic Solutions (MASS) Medscape

1:15PM - 1:55PM
Panel: Meet the needs of an increasingly demanding external environment with a new value-driven medical model
  • Connect and champion patient and real-world data activities throughout your organization by acting as the network between silos
  • Develop and source the new set of capabilities required to enable medical’s full potential
  • Ensure long-term success by adapting now to the next generation of patients, physicians and KOLs with increased access to medical data and research

Ipsen Sotirios Stergiopoulos CMO, SVP and Head of Global Medical Affairs Ipsen

AstraZeneca Sandy Leonard VP of Medical Evidence & Observational Research AstraZeneca

EMD Serono Zhen Su Chief Medical Officer, North America EMD Serono

Alnylam Pharmaceuticals Dr. Pritesh Gandhi PharmD, VP, Medical Affairs Alnylam Pharmaceuticals

1:55PM - 2:25PM
Promoting the patient voice in evidence generation and global market access planning
  • Learn about the challenges of real-world evidence and marketplace demands for supporting new treatments
  • Understand important regulatory and payer perspectives on patient-centric data in decision-making
  • Explore effective examples of leveraging the patient voice in RWE research to leverage direct-to-patient opportunities

PAREXEL Thom Schoenwaelder Vice President PAREXEL

PAREXEL Leanne Larson, MHA Corporate Vice President & WW Head, Real-World Evidence Strategy PAREXEL Consulting

2:25PM - 2:55PM
Direct more meaningful internal policy by representing the patient voice across functions
  • Create a more complete picture of the patient journey by using insights from across stakeholder touchpoints and RWD sources
  • Bring more patient insights inwards with increased direct interaction through advocacy groups and organizations
  • Develop new patient value metrics to better inform approach and effectively communicate need to decision makers

Pfizer Oncology Lynn McRoy Senior Director and Team Lead, Breast Cancer, US Medical Affairs Pfizer Oncology

2:55PM - 3:25PM
Early engagement of Medical Affairs in product development: A new frontier to drive R&D innovation and linking “Proof of Concepts” to “Proof of Medical Value”
  • Bring diverse stakeholder insights (patients, payers, providers) early and successfully into the clinical-regulatory development process
  • Develop “must have” components of TPP and successfully translate into a cohesive end point strategy

Trevena, Inc. Usman Iqbal MD, MPH, MBA, Senior Director, Medical Affairs & HEOR Trevena, Inc.

3:25PM - 3:55PM
Networking Coffee Break in the Exhibition Hall
3:55PM - 4:25PM
Find customer's unmet needs with use of enhanced scientific principles in evidence generation
  • Witness the evolving role of Medical Affairs in translating unmet need into a manageable process
  • Explore how to unlock greater product value and differentiation through the “Evidence Development Process”
  • Understand how this evidence generation management can solve unmet needs more effectively

Nestlé Juan Ochoa Chief Medical Officer, US Nestlé

4:25PM - 4:55PM
Role of Medical Affairs as the “value cockpit” For Life Sciences – transition to become the control center for Medical Value to external and internal stakeholders for clinical and commercial execution
  • Imagine how Medical Affairs can evolve science and evidence-based communication to enhance customer engagement
  • Explore potential applications of digital in managing value & outcomes
  • Learn how to manage the proliferation of data/RWD, while meeting demands for transparency

Cognizant Vyom Bhuta Global Partner, Commercial Life Sciences & Digital Business Cognizant

Cognizant Barinder Marhok Global Practice Lead, Clinical Life Sciences Cognizant

4:55PM - 5:25PM
Embed the patient perspective into drug development to locate undiscovered value
  • Improve strategic decision-making throughout development to enhance patient and business outcomes
  • Connect key advocacy groups, patients and caregivers with internal leadership to form long-term collaboration and exchange direct insights
  • Explore how the “Embracing Carers” initiative is empowering and supporting unpaid caregivers to advocate and drive support of their wellbeing

EMD Serono Scott Williams VP, Head of Global Patient Advocacy and Strategic Relationships EMD Serono

5:25PM - 6:10PM
Panel: Address increased evidence demands with a new pharma-payer value paradigm
  • Define medical’s role with market access colleagues to increase synergy between interactions and maximize on limited contact time available
  • Tailor publication plans to the payer audience with increased understanding of decision-making factors
  • Increase research opportunities and align findings to payer preferences with a focus on collaborative claims in database studies

Blue Cross Blue Shield Association Suzanne Belinson Executive Director, Clinical Markets Blue Cross Blue Shield Association

GSK John Graham VP and Head, Value Evidence and Outcomes GSK

Novartis Vivian Herrera Executive Director, Head of HEOR Payer Strategy Novartis

6:10PM - 7:30PM
Networking Drinks Reception in the Exhibition Hall

PLUS, VIP Dinner Sponsored by Verix. Invite only.

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

7:20AM - 8:20AM
Registration & Welcome Coffee in the Exhibition Hall
Medical Affairs
8:20AM - 8:30AM
Chairperson’s Opening Address

PAREXEL Leanne Larson MHA, Corporate VP & WW Head, Real-World Evidence Strategy PAREXEL

8:30AM - 8:55AM
Expand your RWE horizon: look beyond data generation and explore the multitude of further uses
  • Explore the range of tools to leverage RWE to improve healthcare stakeholder (e.g. patient associations, HCPs, payers) engagement
  • Leverage new technologies to analyse healthcare trends
  • Integrate RWE in the cross-functional communication strategy of your brand value proposition

Novartis Luca Dezzani Global Brand Medical Director Novartis

8:55AM - 9:25AM
The role of registries in patient understanding for Medical Affairs in an era of ‘big data’
  • Understand the full potential of registry data amongst the RWD source spectrum, and how this fits in the realm of ‘big data'
  • Create a complete picture of the patient journey by linking registry data with other RWE sources (claims and EMR) to overcome evidence gaps
  • Explore the full range of registry data uses (comparative effectiveness & safety, cost effectiveness, real-time PRO feedback & analysis)

Corrona Joel Kremer Founder and Chief Medical Officer Corrona

9:25AM - 10:20AM
Roundtables:

Choose from one of the following 6 roundtables:

  1. The modern MSL: what are the skill requirements and how do you achieve them under constrained budgets for maximum value addition?
  2. Digital tools in medical affairs: how focus investment on technological developments for improved customer engagement and insights gathering
  3. Achieving launch excellence: the steps to create unity across Development, Medical Affairs, Access and Commercial teams
  4. Reducing the risk of outcomes-based pricing: explore medical’s role in achieving a new high bar for data requirements
  5. Patient-centricity: a hot topic, but what’s really being done and how do medical help instil a change for good?
  6. Maintaining authenticity: what’s the best approach to balance commercial and scientific pressures?

Roundtable hosts:

AstraZeneca Sandy Leonard VP of Medical Evidence & Observational Research AstraZeneca

UCB Kathy Foris Head of Medical Neurology UCB

Corrona Joel Kremer Founder and Chief Medical Officer Corrona

Pfizer Lori Stockert US Medical Affairs, Director Pfizer

10:20AM - 10:50AM
Networking Coffee Break in the Exhibition Hall
10:50AM - 11:15AM
Inform formulary and regulatory decision-making with pragmatic clinical trial (PCT) data
  • Incorporate real-world evidence study design and data into PCT planning and development
  • Learn best practices of PCT study design and execution from ongoing and completed case examples
  • Discuss regulatory and formulary decision-making considerations incorporating PCT data

AstraZeneca Eric Wittbrodt Director HEOR AstraZeneca

11:15AM - 11:45AM
Leverage the power of technology and data to take Medical Affairs to the next level
  • Map your future with expert data analysis to identify current trends and actionable insights
  • Embrace the potential of AI and VR for competitive advantage
  • Leverage emerging technologies for a personalized learning experience

Medscape Katie Anders Head of Medical Affairs Strategic Solutions (MASS) Medscape

11:45AM - 12:45PM
Lunch in the Exhibition Hall

PLUS Lunch & Learn with viihealth in Room 112A.  For pharma and bio attendees only.

12:45PM - 12:55PM
Workshop Break
12:55PM - 1:20PM
Exponential education: Accelerate the distribution of medical information by embracing Artificial Intelligence (AI)
  • Enable immediate medical request response times by investing in machine learning capabilities, automating a proportion of responses
  • Develop intelligent content personalized to requesters, using self-learning social monitoring technology
  • Become the prime destination for medical information requests by creating a reliable and seamless online interaction experience

BMS Chris Keenan Head, Worldwide Medical Customer Engagement, Medical Capabilities BMS

1:20PM - 2:00PM
Panel: Shape internal direction by effectively measuring and demonstrating medical's value
  • Create tangible KPIs that are easily measurable and relatable in comparative assessment
  • Use quantifiable external feedback on medical interactions to bring insight on field team interactions internally
  • Foster a business-focused mindset within medical teams to drive long-term change toward a more measurable model

Pfizer Eddie Power VP, US Medical Affairs Pfizer

Clinical Score Gary Kaplan VP of Medical Affairs Research Clinical Score

Takeda Canada Jefferson Tea VP Medical & Scientific Affairs Takeda Canada

UCB Kathy Foris Head of Medical Neurology UCB

2:00PM - 2:15PM
Networking Coffee Break in the Exhibition Hall

Chairperson: eyeforpharma Paul Simms Chairman eyeforpharma

2:15PM - 3:10PM
Panel: ‘Value’: focus on the common objectives amidst the chaos
  • Develop the shift to value-based care and explore its potential to set an acceptable ‘new normal’ for drug pricing
  • Discover how best to demonstrate true value of your drug when interacting with a complex array of stakeholders
  • Understand pharma’s unique position in the delivery of healthcare to understand which partnerships and collaborations are required, moving forwards

Novartis Fabrice Chouraqui President, U.S. Novartis

Lilly Oncology Sue Mahony SVP & President Lilly Oncology

PhRMA Stephen Ubl President & CEO PhRMA

V ClinBio Bob Oliver CEO & President V ClinBio

Kaiser Permanente Amy Gutierrez, Pharm.D. Vice President, Chief Pharmacy Officer Kaiser Permanente

Moderator: Legacy Health Strategies Rolf Benirschke Co-Founder and Co-CEO Legacy Health Strategies

3:10PM - 3:15PM
Announcement of the Lifetime Achievement Award Winner
3:15PM - 3:30PM
Presentation from the Winner of the Most Valuable Pharma Collaboration
3:30PM - 3:55PM
Consolidation or Transformation?
  • Learnabout a new regulatory pathway for innovative drug products that reduces time, risks and costs and can lead to increased R&D productivity
  • Explorenew commercial models that expand the definition of a pharmaceutical product and create significant new barriers to entry that do not require patents on molecules
  • Discover new manufacturing methods that build on the industry’s high volume, high quality expertise and incorporate new disciplines from the semiconductor industry

proteus_digital_health Andy Thompson CEO & co-founder Proteus Digital Health

3:55PM - 4:40PM
Panel: Big data, bigger opportunity
  • Envisage the monumental long-term effect of real world data informing customers as well as ourselves; particularly with regard to drug discovery, patient access and commercialization
  • Understand the trajectory and adoption of sensors to collect real-time patient insight and their future implications
  • Realize the potential in the analytics of vast quantities of data and where this will influence prescribers, payers, policy makers and other stakeholders

Abbvie Rob Scott Vice President, Development and Chief Medical Officer Abbvie

EMD Serono Zhen Su Senior Vice President & CMO EMD Serono

Moderna Therapeutics Marcello Damiani Chief Digital Officer Moderna Therapeutics

Pfizer Chris Boone VP, Real World Data & Analytics Center of Excellence, Patient & Health Pfizer

Salesforce Susan Emerson VP, Analytics and AI Salesforce

Moderator: Amazon Web Services Lita Sands Global Life Sciences Principal Amazon Web Services

4:40PM
End of Summit

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription